Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: billy d who wrote (901)	6/17/1998 8:43:00 PM
From: M. Ramle	Read Replies (2) \| Respond to of 10280

Billy d: I have been a SEPR shareholder for the last 1 1/2 years, and I believe I have been through some of the up-down-down-up cycles before with this company, but never before has the come-back been so frustrating and antagonizing like this. Even with SmartMoney On-line recommended article a couple of days ago has failed to pop the price up. THIS IS OBVIOUSLY AN ABSOLUTE MANIPULATION BY THE MARKET MAKERS, AND THE SEC SHOULD DEFINITELY LOOK INTO IT !!!! I might very well call the SEC myself and complain about this ill-practice by the Market Makers. Anyway, I feel we are getting very close to an FDA announcement on levalbuterol (which I hope will be positive). If you look at the weekly chart with the 200-day MA, it looks like we are in the processing of forming an inverted head-and-shoulder with the base around the $37-$38. In order to confirm this formation, we should close the week (triple-witching Friday) above the $41 mark, which would be extremely positive. Also, a number of the well-known biotech. stocks seem to be regaining their momentum, and maybe this will give a boost to SEPR, which was started by Bear Stearns with an <<Attractive>> coverage. Anyway, thanks for the moral boost. GOOD LUCK Mazen